Advancements in 3D Printing and Stem Cell Therapy offer Hope for Diabetes Treatment

TL;DR
Erin Bedford, head of bioprinting innovation at Aspect Biosystems, is leading a team that is developing a 3D printing process to create human pancreas cells for the treatment of Type 1 diabetes. The technology involves printing insulin-producing cells that can be injected into the body, potentially eliminating the need for organ transplants. Human trials are expected to begin soon, and the company has received a $75 million investment from Novo Nordisk. Aspect Biosystems is also exploring the possibility of printing other organs, such as livers.
Topics:healthhealthtech#bioprinting#diabetes#healthtech#medical-innovation#nanotechnology#stem-cells
- How Aspect Biosystems is treating diabetes with 3D printing Quartz
- Experimental implant could end the need for insulin injections Freethink
- Two KCL research projects awarded £4.8m to help find cure for type 1 diabetes PMLiVE
- Stem Cell Therapy: A Potential Cure for T1D Medriva
- New cell therapy to “switch off” the effects of type 1 diabetes Diabetes Australia
Want the full story? Read the original reporting
Read on Quartz